Questions about this study?
The HopeStage team will email you.
Active Not RecruitingNCT06615557
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Medication studyAges 18–65United States
Understand this study
Who could participate?
This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- Phoenix, United States · Little Rock, United States and 22 more locationsSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo described in the protocol; its role is not resolved here
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 16, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 238
- Sponsor
- VistaGen Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06615557
- Official title
Show the full official title
US, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-4)
Recruitment & locations
Not recruitingPhoenix · Little Rock · Bellflower
21 more locations
- Oceanside
- Orange
- Redlands
- Torrance
- Denver
- Tampa
- Decatur
- Chicago
- Naperville
- Boston
- Bloomfield Township
- Flowood
- Las Vegas
- Albuquerque
- New York
- Cincinnati
- Austin
- Dallas
- Houston
- San Antonio
- Everett
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is VistaGen Therapeutics, Inc.
Does this study involve medication?
Yes. The study involves medication, including Fasedienol Nasal Spray and Placebo Nasal Spray.
Who can participate?
This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me